Swiss National Bank
AVEO

Swiss National Bank’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Swiss National Bank’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-75,200
Closed -$1.12M – 2712
2022
Q4 		$1.12M Buy
+75,200
New +$1.04M ﹤0.01% 2282
2013
Q4 		– Sell
-5,320
Closed -$110K – 2529
2013
Q3 		$110K Hold
5,320
– – ﹤0.01% 2445
2013
Q2 		$133K Buy
+5,320
New +$227K ﹤0.01% 2440

Swiss National Bank's AVEO Position: Q1 2023 in Review

Swiss National Bank sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 75,200 shares — an estimated $1.12M sold.

Swiss National Bank first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $1.12M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Swiss National Bank reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 75,200 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.12M.
  • Swiss National Bank first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Swiss National Bank's AVEO Pharmaceuticals, Inc. position peaked at $1.12M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.